Inhibrx Profit Margin 2020-2022 | INBX
Current and historical gross margin, operating margin and net profit margin for Inhibrx (INBX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Inhibrx net profit margin as of March 31, 2022 is -1289.14%.
|Inhibrx Annual Profit Margins
|Inhibrx Quarterly Profit Margins
||Medical - Biomedical and Genetics
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.